Going concern
Filing comparison
NOVAVAX INC no longer discloses a going-concern conclusion
Substantial doubt raised, alleviated by management's plans → No going-concern disclosure
During the year ended December 31, 2025, the Company recognized net income of $440.3 million and had net cash flows used in operating activities of $244.6 million. In accordance with Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern, the Company evaluated its ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. Based on the Company’s current cash, cash equivalents, and marketable securities balances and the Company's current cash flow forecast for the one-year…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- none
- Current state label
- No going-concern disclosure
- Direction
- eased
- Located in
- going-concern note
- Prior filed
- 2025-02-27
- Prior form
- 10-K
- Prior state
- doubt_alleviated
- Prior state label
- Substantial doubt raised, alleviated by management's plans
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.